<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02533284</url>
  </required_header>
  <id_info>
    <org_study_id>5</org_study_id>
    <nct_id>NCT02533284</nct_id>
  </id_info>
  <brief_title>Magnesium Sulfate for TAP Analgesia During Laparoscopic Cholecystectomy</brief_title>
  <official_title>Magnesium Sulfate for TAP Analgesia During Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study the effect of adding Magnesium sulfate to TAP block in analgesia after laparoscopic
      cholecystectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval of local ethical committee, consent will be obtained from 90 patients
      scheduled for laparoscopic cholecystectomy in GEC center, Mansoura University, Egypt.
      Patients will be of either ASA I and II, with Age ranging from 18-40 years, and BMI less than
      35. Patients will be randomized into 3 groups (using closed envelope technique in blocks of
      18); Controlled group (C group), Bupivacaine group (B group), Bupivacaine Magnesium group (M
      group).

      Anesthesia induction will be the same in the three groups (Propofol 1-1.5mglkg, Fentanyl 1
      mic/kg, Atracrium 0.5 mg/kg) then Sevoflorane inhalational anesthesia for maintainace in 0.4
      oxygen/air mixtures.

      In both M group and B group, preemptive US guided Subcostal TAP block (Toshiba Xario, Japan)
      was performed on both sides using 20 ml volume (0.25 Bupivacaine in B group or 0.25
      Bupivacaine plus 0.5 gm MgSo4 in M group). Surgical sterilization will be started 5 minutes
      after the block and surgery started5 minutes later. Hemodynamic data (HR, MAP) will be
      collected immediately after induction, at start of surgery, and each 10 minutes later.

      At the end of surgery, and after closure of surgical ports, anesthesia was terminated and
      extubation done when patients fulfilled the required criteria. Postoperative hemodynamic data
      (HR, MAP), VAS, and PONV will berecorded at 0, 1, 2, 6, 12, 24 hours after surgery, Ramsay
      sedation was recorded at 0, 1, 2, 6 hours postoperatively. Boluses of Morphine (0.02 mg/kg)
      will be given whenever VAS â‰¥4.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesia after laparoscopic cholecystectomy</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Magnesium sulfate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>US guided TAP with magnesium sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAP bupevecaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control TAP saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>preemptive US guided TAP block will be done using Bupivacaine 0.25% plus 0.5 gm MgSo4 in M group).</description>
    <arm_group_label>Magnesium sulfate group</arm_group_label>
    <other_name>Group 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupevecaine</intervention_name>
    <description>US guided TAP using Bupevecaine 0.25 %</description>
    <arm_group_label>Magnesium sulfate group</arm_group_label>
    <arm_group_label>B group</arm_group_label>
    <other_name>group 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>US guided TAP using placebo (saline)</description>
    <arm_group_label>C group</arm_group_label>
    <other_name>group3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I, II for lap cholecystectomy

        Exclusion Criteria:

          -  ASA III, IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alrefaey Kandeel, MD</last_name>
    <phone>00201008158591</phone>
    <email>refa3ey2@yahioo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>Dkahleya</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alreafey Kandeel, MD</last_name>
      <phone>00201008158591</phone>
      <email>refa3ey2@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2015</study_first_posted>
  <last_update_submitted>August 22, 2015</last_update_submitted>
  <last_update_submitted_qc>August 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>AlRefaey Kandeel</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 19, 2016</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>October 25, 2016</submitted>
    <returned>December 13, 2016</returned>
    <submitted>February 13, 2017</submitted>
    <returned>March 30, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

